Abstract
We report the genome sequence of Xenorhabdus szentirmaii DSM16338 (4.84 Mb), a symbiont of the entomopathogenic nematode Steinernema rarum. This strain produces antimicrobial activity.
GENOME ANNOUNCEMENT
Xenorhabdus is a symbiont of nematodes of the family Steinernematidae, pathogenic for a wide variety of insects (1). The entomopathogenic nematodes are used as biological control agents for soil-inhabiting insects (2). The Xenorhabdus genus is also a source of secondary metabolites (3). These metabolites are bioactive molecules with a broad spectrum of potential functions, such as insecticidal, antitumor, and antimicrobial activities. In the course of antimicrobial screening on culture supernatants of a collection of Xenorhabdus strains, we identified Xenorhabdus szentirmaii DSM16338 as an important producer of antimicrobial activity, a property previously described by other authors (4–6).
We sequenced Xenorhabdus szentirmaii DSM16338, a symbiont of the entomopathogenic nematode Steinernema rarum from Argentina (7). The genomic DNA was purified from our laboratory stock according to the method of Brenner et al. (8). The sequencing strategy was conducted by GATC Biotech (Konstanz, Germany). We used a mixed sequencing strategy with Roche 454 GS-FLX titanium and Illumina technologies. Sequencing of a 450-nucleotide mate-paired library with a GS FLX sequencer resulted in 271,899 reads with a median length of 334 nucleotides. Semiautomatic GS FLX assembly generated 169 contigs comprising a total length of 4.82 Mb. Sequencing of a 3-kb paired-end library with an Illumina HiSeq 2000 sequencer (read length: 2 × 50 nucleotides) resulted in 40,772,101 read pairs that were used for mapping against the GS FLX data with homopolymer correction. The final assembly consisted of 164 contigs comprising a total length of 4.84 Mb (4.82 Mb without undetermined bases) and has a 43.98% GC.
Functional annotation was carried out using tools of the MicroScope platform (9). The annotated genomes were implemented in the public XenorhabduScope database (https://www.genoscope.cns.fr/agc/microscope/home/index.php). The assembly of X. szentirmaii DSM16338 contains 4,794 genomic objects, including 4,680 coding sequences, 4 rRNA genes, 58 tRNA genes, and 23 noncoding RNAs. Genome annotation highlighted the presence of 71 genes encoding nonribosomal peptide synthetases and polyketide synthases in X. szentirmaii DSM16338. Therefore, this bacterium is a promising reservoir for nonribosomally synthesized peptides with new bioactive effects, such as antimicrobial activities. Further genomic analyses will be performed to identify gene clusters for biosynthesis of antimicrobial molecules.
Nucleotide sequence accession numbers.
This whole-genome shotgun project has been deposited at EMBL under the accession no. CBXF000000000. The version described in this paper is the first version, CBXF010000000.
ACKNOWLEDGMENT
The work was funded by Nosopharm.
Footnotes
Citation Gualtieri M, Ogier J-C, Pagès S, Givaudan A, Gaudriault S. 2014. Draft genome sequence and annotation of the entomopathogenic bacterium Xenorhabdus szentirmaii strain DSM16338. Genome Announc. 2(2):e00190-14. doi:10.1128/genomeA.00190-14.
REFERENCES
- 1. Nielsen-LeRoux C, Gaudriault S, Ramarao N, Lereclus D, Givaudan A. 2012. How the insect pathogen bacteria Bacillus thuringiensis and Xenorhabdus/Photorhabdus occupy their hosts. Curr. Opin. Microbiol. 15:220–231. 10.1016/j.mib.2012.04.006 [DOI] [PubMed] [Google Scholar]
- 2. Ehlers RU. 2001. Mass production of entomopathogenic nematodes for plant protection. Appl. Microbiol. Biotechnol. 56:623–633. 10.1007/s002530100711 [DOI] [PubMed] [Google Scholar]
- 3. Bode HB. 2009. Entomopathogenic bacteria as a source of secondary metabolites. Curr. Opin. Chem. Biol. 13:224–230. 10.1016/j.cbpa.2009.02.037 [DOI] [PubMed] [Google Scholar]
- 4. Fodor A, Fodor AM, Forst S, Hogan JS, Klein MG, Lengyel K, Saringer G, Stackebrandt E, Taylor RAJ, Lehoczky E. 2010. Comparative analysis of antibacterial activities of Xenorhabdus species on related and nonrelated bacteria in vivo. J. Microbiol. Antimicrob. 2:36–46 [Google Scholar]
- 5. Böszörményi E, Érsek T, Fodor A, Fodor AM, Földes LS, Hevesi M, Hogan JS, Katona Z, Klein MG, Kormány A, Pekár S, Szentirmai A, Sztaricskai F, Taylor RA. 2009. Isolation and activity of Xenorhabdus antimicrobial compounds against the plant pathogens Erwinia amylovora and Phytophthora nicotianae. J. Appl. Microbiol. 107:746–759. 10.1111/j.1365-2672.2009.04249.x [DOI] [PubMed] [Google Scholar]
- 6. Furgani G, Böszörményi E, Fodor A, Máthé-Fodor A, Forst S, Hogan JS, Katona Z, Klein MG, Stackebrandt E, Szentirmai A, Sztaricskai F, Wolf SL. 2008. Xenorhabdus antibiotics: a comparative analysis and potential utility for controlling mastitis caused by bacteria. J. Appl. Microbiol. 104:745–758. 10.1111/j.1365-2672.2007.03613.x [DOI] [PubMed] [Google Scholar]
- 7. Lengyel K, Lang E, Fodor A, Szállás E, Schumann P, Stackebrandt E. 2005. Description of four novel species of Xenorhabdus, family Enterobacteriaceae: Xenorhabdus budapestensis sp. nov., Xenorhabdus ehlersii sp. nov., Xenorhabdus innexi sp. nov., and Xenorhabdus szentirmaii sp. nov. Syst. Appl. Microbiol. 28:115–122. 10.1016/j.syapm.2004.10.004 [DOI] [PubMed] [Google Scholar]
- 8. Brenner DJ, McWhorter AC, Knutson JK, Steigerwalt AG. 1982. Escherichia vulneris: a new species of Enterobacteriaceae associated with human wounds. J. Clin. Microbiol. 15:1133–1140 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Vallenet D, Belda E, Calteau A, Cruveiller S, Engelen S, Lajus A, Le Fèvre F, Longin C, Mornico D, Roche D, Rouy Z, Salvignol G, Scarpelli C, Thil Smith AA, Weiman M, Médigue C. 2013. MicroScope—an integrated microbial resource for the curation and comparative analysis of genomic and metabolic data. Nucleic Acids Res. 41:D636–D647. 10.1093/nar/gks1194 [DOI] [PMC free article] [PubMed] [Google Scholar]